Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
Think Academy concluded its participation at CES 2026 after generating strong interest around Class+, its AI-powered Intelligent Learning System, and a broader portfolio of education technology ...
Cold plunge therapy sits in an interesting place in the recovery landscape. The evidence for short-term recovery benefits and ...
Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...
11h
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.
FDA oral Wegovy, solid fundamentals, and low P/E vs. Eli Lilly. Click for this updated look at NVO stock prospects as ...
ABCmouse, the award-winning early learning platform trusted by families and educators for more than 15 years, today launched an all-new version of its program?completely reimagined to bring the magic ...
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ResearchAndMarkets.com's ...
Detailed price information for Allogene Therapeutics Inc (ALLO-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback